欢迎访问西亚试剂!
西亚试剂banner
西亚试剂banner
西亚试剂banner

当前位置:首页 > 新闻中心

西亚试剂:Naturally Occurring Neomorphic PIK3R1 Mutations Activate th

发布时间:2025-07-12

PIK3R1 (p85α regulatory subunit of PI3K) is frequently mutated across cancer lineages. Herein, we demonstrate that the most common recurrent PIK3R1 mutation PIK3R1R348∗ and a nearby mutation PIK3R1L370fs, in contrast to wild-type and mutations in other regions of PIK3R1, confers an unexpected sensitivity to MEK and JNK inhibitors in vitro and in vivo. Consistent with the response to inhibitors, PIK3R1R348∗ and PIK3R1L370fs unexpectedly increase JNK and ERK phosphorylation. Surprisingly, p85α R348∗ and L370fs localize to the nucleus wher the mutants provide a scaffold for multiple JNK pathway components facilitating nuclear JNK pathway activation. Our findings uncover an unexpected neomorphic role for PIK3R1R348∗ and neighboring truncation mutations in cellular signaling, providing a rationale for therapeutic targeting of these mutant tumors.以上资料由西亚试剂http://www.xiyashiji.com/提供

上一篇:西亚试剂:两种DNA酶拮抗作用失衡会导致DNA编码读取错误
下一篇:有青霉素过敏记录的人易得超级细菌感染
版权所有:山东西亚化学有限公司

鲁ICP备20015914号-4